Home 
Bratislava Medical Journal 2020 Bratislava Medical Journal Vol.121, No.11, p.812–816,2020
Bratislava Medical Journal 2020 Bratislava Medical Journal Vol.121, No.11, p.812–816,2020
Journal info
|
||||
Select Journal
Journals
Acta Virologica Bratislava Medical Journal Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.121, No.11, p.812–816,2020 |
||
| Title: The probable role of insulin resistance and SIRT1 proteins in the Alzheimer’s disease | ||
| Author: R. Tural, N. Altan, C. Irkec, D. Sahin, H. Z. Batur Caglayan | ||
| Abstract: OBJECTIVE: Recent evidence suggests that insulin resistance may play an important role in the pathogenesis of Alzheimer’s disease (AD). In this study, the probable role of insulin resistance in the pathogenesis of AD was investigated in patients with Type 2 Diabetes Mellitus (T2DM). METHODS: Serum amyloid beta (Aβ) (1-42), insulin like growth factor-1 (IGF-1), sirtuin1 (SIRT1) and leptin protein levels were measured in serum samples of control (n = 26), probable AD (n = 26), and probable AD+T2DM patients (n = 12) using ELISA method. Mini mental state examination (MMSE) was performed to the patient and control groups. RESULT: Serum IGF-1 significantly increased in the probable AD+T2DM group as compared to the control and probable AD groups (p ˂ 0.05). The levels of serum leptin significantly decreased in the probable AD and AD+T2DM groups as compared to the control (p ˂ 0.05). There were no statistically significant differences in serum Aβ (1-42) and SIRT1 levels among groups (p > 0.05). CONCLUSION: The significant decrease in serum leptin levels in AD patients may indicate that it may be a therapeutic marker in AD. The level of serum Aβ peptide and SIRT1 proteins can vary depending on the stage of the disease. Therefore, this study should be supported by more comprehensive studies in terms of the number of patients in advanced stage (Tab. 1, Fig. 4, Ref. 29). |
||
| Keywords: Alzheimer disease, diabetes mellitus, insulin, IGF-1, amyloid beta (Aβ), sirtuin 1 (SIRT1), leptin | ||
| Published online: 09-Nov-2020 | ||
| Year: 2020, Volume: 121, Issue: 11 | Page From: 812, Page To: 816 | |
| doi:10.4149/BLL_2020_133 |
||
|
|
 download file |
|